| Study on the Use of Interferon Gamma (Ingaron) Injections in Patients With Drug-resistant Pulmonary Tuberculosis (NCT05359315) | SPP Pharmaclon Ltd. | 2022-04-15 |
| Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) (NCT04930744) | University of Massachusetts, Worcester | 2022-03-04 |
| Study on Three Doses of an Inactivated COVID-19 Vaccine in Chinese Pulmonary Tuberculosis Patients (NCT05148949) | Jiangsu Province Centers for Disease Control and Prevention | 2021-12-22 |
| PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE) (NCT04550832) | LigaChem Biosciences, Inc. | 2021-10-28 |
| Development of an Artificial Intelligence System for Intelligent Pathological Diagnosis and Therapeutic Effect Prediction Based on Multimodal Data Fusion of Common Tumors and Major Infectious Diseases in the Respiratory System Using Deep Learning Technology. (NCT05046366) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2021-10-01 |
| Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases (NCT04857814) | University of Alberta | 2021-07-01 |
| PanACEA Sutezolid Dose-finding and Combination Evaluation (NCT03959566) | Michael Hoelscher | 2021-05-06 |
| Novel Triple-dose Tuberculosis Retreatment Regimen (NCT04260477) | Institute of Tropical Medicine, Belgium | 2021-03-01 |
| Diagnostic Accuracy of CAD4TB and C-reactive Protein Assay as Triage Tests for Pulmonary Tuberculosis (NCT04666311) | Klaus Reither | 2021-02-15 |
| Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081 (NCT04608955) | Shanghai Jiatan Pharmatech Co., Ltd | 2020-10-16 |
| Rosuvastatin Evaluation as a Tuberculosis Treatment Adjunct (NCT04504851) | National University Hospital, Singapore | 2020-08-12 |
| Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB (NCT04187469) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2020-03-01 |
| StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis (NCT03882177) | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-02-21 |
| Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis (NCT04176250) | Gates Medical Research Institute | 2020-01-16 |
| A Study of Pattern of Presentation of Pulmonary Tuberculosis Patients Undergoing Treatment at Assiut University Hospital (NCT04055441) | Assiut University | 2019-09-01 |
| PRACTECAL-PKPD Sub Study (NCT04081077) | Medecins Sans Frontieres, Netherlands | 2019-08-06 |
| Trial of Faropenem and Cefadroxil (in Combination With Amoxicillin/Clavulanic Acid and Standard TB Drugs) in Patients With Pulmonary Tuberculosis: Measurement of Early Bactericidal Activity and Effects on Novel Biomarkers (NCT02381470) | National University Hospital, Singapore | 2019-02-11 |
| Tuberculosis Cohort in the North of Paris (NCT04236349) | Assistance Publique - Hôpitaux de Paris | 2018-05-01 |
| Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis (NCT05896930) | TASK Applied Science | 2017-11-09 |
| Joint Management of DM2 and Pulmonary TB in Orizaba, Veracruz (NCT03277742) | Instituto Nacional de Salud Publica, Mexico | 2017-09-20 |
| Using Biomarkers to Predict TB Treatment Duration (NCT02821832) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-06-21 |
| A Randomised Trial to Evaluate Toxicity and Efficacy of 1200mg and 1800mg Rifampicin for Pulmonary Tuberculosis (NCT02581527) | St George's, University of London | 2017-02-01 |
| A Phase II Clinical Study of LCB01-0371 to Evaluate the EBA, Safety and PK (NCT02836483) | LigaChem Biosciences, Inc. | 2016-12-10 |
| Structural and Functional Repercussions of Pulmonary Tuberculosis Sequelae (NCT02736864) | Federal University of Uberlandia | 2016-09-28 |
| Evaluation of Host Biomarker-based Point-of-care Tests for Targeted Screening for Active TB (NCT03350048) | Prof Gerhard Walzl | 2016-04-01 |
| Phase 2a ID93 + GLA-SE Vaccine Trial in TB Patients After Treatment Completion (NCT02465216) | Access to Advanced Health Institute (AAHI) | 2015-06-01 |
| Assessing PA-824 for Tuberculosis (the APT Trial) (NCT02256696) | Johns Hopkins University | 2015-04-29 |
| A Phase 3 Trial Assessing Safety and Efficacy of B-Pa-L in Participants With DR-TB (NCT02333799) | Global Alliance for TB Drug Development | 2015-03-01 |
| NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis (NCT02371681) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-02-25 |
| Effect of Supplementary Vitamin D in Patients With Diabetes Mellitus and Pulmonary Tuberculosis (NCT02169570) | Dow University of Health Sciences | 2014-12-01 |
| A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001) (NCT02279875) | Global Alliance for TB Drug Development | 2014-11-01 |
| Prospective Assessment of TBDx Feasibility (NCT02912832) | Foundation for Innovative New Diagnostics, Switzerland | 2014-10-01 |
| Phase 2 Trial to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Meropenem Plus Amoxycillin/CA and Faropenem Plus Amoxycillin/CA in Adult Patients With Newly Diagnosed Pulmonary Tuberculosis (NCT02349841) | TASK Applied Science | 2014-09-01 |
| Pulmonary Tuberculosis Patients With Diabetes Mellitus (NCT02106039) | Universitas Padjadjaran | 2014-04-28 |
| Effect of Vitamin D as Adjunctive Therapy in Patients With Pulmonary Evolution Tuberculosis (NCT02464683) | Instituto Nacional de Enfermedades Respiratorias | 2014-04-01 |
| Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia (NCT02554318) | University of Giessen | 2013-11-01 |
| Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult Volunteers (NCT01927159) | Access to Advanced Health Institute (AAHI) | 2013-09-01 |
| Intervention in the Management of Post-high Tuberculosis Hospital Through Educational Strategy and Oversight Distance (NCT02558842) | Hospital de Clinicas de Porto Alegre | 2013-03-01 |
| Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis (NCT02467608) | Orient Pharma Co., Ltd. | 2012-12-06 |
| Phase 1 ID93 + GLA-SE Vaccine Trial in Healthy Adult Volunteers (NCT01599897) | Access to Advanced Health Institute (AAHI) | 2012-08-01 |
| Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002) (NCT01498419) | Global Alliance for TB Drug Development | 2012-03-01 |
| Evaluation of PTB Screening in ANC in Lusaka, Zambia (NCT02053129) | University of North Carolina, Chapel Hill | 2011-11-01 |
| Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis (NCT02313610) | Shanghai University of Traditional Chinese Medicine | 2011-04-01 |
| Clinical Trial of Phenylbutyrate and Vitamin D in Tuberculosis (TB) (NCT01580007) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2010-12-01 |
| Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001) (NCT01215851) | Global Alliance for TB Drug Development | 2010-10-01 |
| Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001) (NCT01215110) | Global Alliance for TB Drug Development | 2010-04-01 |
| Latency in Pulmonary Tuberculosis (NCT01154959) | Tuberculosis Research Centre, India | 2010-02-01 |
| A Clinical Trial to Study the Effect of the Addition of Vitamin D to Conventional Treatment in New Pulmonary Tuberculosis Patients (NCT00366470) | Peter Daley | 2009-11-01 |
| Tuberculosis Volatile Organic Compounds (NCT01379066) | Landon Pediatric Foundation | 2009-08-01 |
| Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010) (NCT00944021) | Global Alliance for TB Drug Development | 2009-08-01 |
| Induced Sputum Versus Bronchoscopy in Smear Negative Pulmonary Tuberculosis (NCT01011543) | Centre Hospitalier Universitaire Saint Pierre | 2009-08-01 |
| Pharmacokinetic Study for Anti-tuberculosis Drugs (NCT00948077) | Taipei Medical University WanFang Hospital | 2009-07-01 |
| Prevalence and Clinical Significance of Co-infection of Mycoplasma Pneumoniae in Patients With Pulmonary Tuberculosis (NCT00926601) | Seoul National University Hospital | 2009-06-01 |
| Pharmacokinetic Study of Patients Who Undergo Cycloserine, a 2nd-line Antituberculosis Medicament (NCT01002170) | Taipei Medical University WanFang Hospital | 2009-05-01 |
| Directly Observed Therapy Short Course-Plus Versus DOTS for Retreatment of Relapsed Pulmonary Tuberculosis in Guangzhou (NCT01618422) | Chinese University of Hong Kong | 2009-03-01 |
| TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment (NCT00694629) | Centers for Disease Control and Prevention | 2008-12-01 |
| Linezolid to Treat Extensively-Drug Resistant Tuberculosis (NCT00727844) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-07-01 |
| Isoniazid Dose Adjustment According to NAT2 Genotype (IDANAT2) (NCT00571753) | University of Cologne | 2008-06-01 |
| Efficacy of Oral Zinc Administration as an Adjunct Therapy in New Pulmonary Tuberculosis (Category I) Patients (NCT00698386) | Ministry of Science and Technology, India | 2008-02-01 |
| Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis (NCT00864383) | Global Alliance for TB Drug Development | 2008-01-01 |
| PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (NCT00567840) | Global Alliance for TB Drug Development | 2007-08-01 |
| Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis (NCT00401271) | Otsuka Frankfurt Research Institute GmbH | 2006-11-01 |
| Improving Community Based Tuberculosis Care in Ethiopia (NCT00803322) | University of Bergen | 2006-09-01 |
| Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis (NCT00772408) | Chang Gung Memorial Hospital | 2006-08-01 |
| Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis (NCT00834353) | Maulana Azad Medical College | 2005-09-01 |
| Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT) (NCT00298870) | Osaka University | 2005-06-01 |
| Cytokines and Acute Phase Reactants as Markers of Pulmonary Tuberculosis Treatment (NCT00517231) | UPECLIN HC FM Botucatu Unesp | 2005-06-01 |
| Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis (NCT01242592) | NMP Medical Research Institute | 2005-02-01 |
| Vitamin A Therapy for Tuberculosis (NCT00057434) | National Institute of Allergy and Infectious Diseases (NIAID) | 1998-09-01 |
| TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis (NCT00023335) | Centers for Disease Control and Prevention | 1995-04-01 |